Serum calcium levels are elevated among women with untreated postmenopausal breast cancer

Cancer Causes and Control

Volumn 21, Issue 2, 2010, Pages 251-257

  Martin, Erica ^a   Miller, Megan ^a   Krebsbach, Lacey ^a   Beal, James R ^a   Schwartz, Gary G ^b   Sahmoun, Abe E ^c  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UND School of Medicine & Health Sciences Southeast Campus   (United States)

Author keywords

Breast cancer; Epidemiology; Postmenopausal; Primary hyperparathyroidism; Serum calcium

Indexed keywords

CALCIUM; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

AGED; ARTICLE; BREAST CANCER; CALCIUM BLOOD LEVEL; CANCER SIZE; CANCER STAGING; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OBESITY; PREVALENCE; PRIORITY JOURNAL; UNITED STATES;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CALCIUM; CASE-CONTROL STUDIES; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; HYPERPARATHYROIDISM; NORTH DAKOTA; POSTMENOPAUSE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TUMOR BURDEN;

EID: 77950692152     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9456-2     Document Type: Article

References (23)

1. Cancer facts and figures (2009) American Cancer Society
2. American Cancer Society. Breast Cancer Facts & Figures (2005-2006) American Cancer Society, Inc., Atlanta
3. Colditz GA, Rosner B (2000) Cumulative risk of breast cancer to age 70 years according to risk factor status: data from, the Nurses' Health Study. Am J Epidemiol 152:950-964
4. Pal SK, Blazer K, Weitzel J, Somlo G (2009) An association between invasive breast cancer and familial idiopathic hyperparathyroidism: a case series and review of the literature. Breast Cancer Res Treat 115:1-5
5. Garner CN, Ganetzky R, Brainard J et al (2007) Increased prevalence of breast cancer among patients with thyroid and parathyroid disease. Surgery 142:806-813 (Pubitemid 350184096)
6. Michels KB, Xue F, Brandt L, Ekbom A (2004) Hyperparathyroidism and subsequent incidence of breast cancer. Int J Cancer 110(3):449-451 (Pubitemid 38649899)
7. Palmer M, Adami HO, Krusemo UB, Ljunghall S (1988) Increased risk of malignant diseases after surgery for primary hyperparathyroidism.. A nationwide cohort study. Am J Epidemiol 127(5): 1031-1040
8. Nilsson IL, Zedenius J, Yin L, Ekbom A (2007) The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy. Endocr Relat Cancer 14:135-140 (Pubitemid 47521729)
9. Camacho PM, Dayal AS, Diaz JL et al (2008) Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis. J Clin Oncol 26(33):5380-5385
10. Worcester EM, Coe FL (2008) New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol 28(2): 120-132 (Pubitemid 351400300)
11. EvanRA,HillsE,WongSP,WyndhamLE,EadeY,DunstanCR(1984) Thepathogenesisofidiopathichypercalciuria:evidenceforparathyroidhyperfunction. QJMed53:41-53(Pubitemid14049028)
12. FierabracciP,PincheraA,MiccoliPetal(2001) Increasedprevalenceofprimaryhyperparathyroidismintreatedbreastcancer. JEndocrinolInvest24(5):31.5-320(Pubitemid32492367)
13. Jorde R, Sundsfjord J, Bønaa A (2001) Determinants of serum calcium in men and women. The Tromsø study. Eur J Epidemiol 17:1117-1123 (Pubitemid 36013853)
14. WysolmerskiJJ,BroadusAE(1994)Hypercalcemiaofmalignancy: thecentralroleofparathyroidhormone-relatedprotein.AnnuRevMed45: 189-200(Pubitemid24985966)
15. Almquist M, Manjer J, Bondeson L, Bondeson AG (2007) Serum calcium and breast cancer risk: results from a prospective cohort study of 7, 847 women. Cancer Causes Control. 18(6):595-602 (Pubitemid 46883676)
16. Almquist M, Anagnostaki L, Bondeson L et al (2009) Serum calcium and tumour aggressiveness in breast cancer: a prospective study of 7847 women. Eur J Cancer Prev 18(5):354-360
17. Calvi LM, Bushinsky DA (2008) When is it appropriate to order an ionized calcium? J Am Soc Nephrol 19:1257-1260
18. Coates R, Clark WS, Eley W, Greenberg RS, Huguley CM Jr, Brown RL (1990) Race, nutritional status and survival from breast cancer. JNCI 82:1684-1692
19. Cheng I, Klingensmith ME, Chattopadhyay N et al (1998) Identification and localization of the extracellular calcium-sensing receptor in human breast. J Clin Endocrinol Metab 83(2): 703-707 (Pubitemid 28496562)
20. Skinner HG, Schwartz GG (2008) Serum, calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 17(9): 2302-2305
21. Skinner HG, Schwartz GG (2009) A prospective study of total and ionized serum calcium and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 18(2):575-578
22. Mann GB, Kang YC, Brand C, Ebeling PR, Miller JA (2009) Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance. J Clin Oncol 27(22):3605-3610
23. Nakamura Y, Bando H, Shintani Y, Yokogoshi Y, Saito S (1992) Serum parathyroid hormone-related protein concentrations in patients with hematologic malignancies or solid tumors. Acta Endocrinol (Copenh) 127(4):324-330